Compare FLNC & EVO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | FLNC | EVO |
|---|---|---|
| Founded | 2018 | 1993 |
| Country | United States | Germany |
| Employees | N/A | 4766 |
| Industry | Industrial Machinery/Components | Biotechnology: Pharmaceutical Preparations |
| Sector | Miscellaneous | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 2.2B | 821.2M |
| IPO Year | 2021 | N/A |
| Metric | FLNC | EVO |
|---|---|---|
| Price | $15.09 | $2.50 |
| Analyst Decision | Hold | Strong Buy |
| Analyst Count | 18 | 1 |
| Target Price | ★ $16.93 | $7.00 |
| AVG Volume (30 Days) | ★ 3.6M | 110.1K |
| Earning Date | 05-06-2026 | 05-05-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ N/A |
| EPS | N/A | ★ N/A |
| Revenue | ★ $2,262,830,000.00 | N/A |
| Revenue This Year | $51.18 | N/A |
| Revenue Next Year | $21.37 | $7.13 |
| P/E Ratio | ★ N/A | N/A |
| Revenue Growth | N/A | ★ N/A |
| 52 Week Low | $3.46 | $2.31 |
| 52 Week High | $33.51 | $4.80 |
| Indicator | FLNC | EVO |
|---|---|---|
| Relative Strength Index (RSI) | 39.36 | 36.10 |
| Support Level | $13.92 | $2.31 |
| Resistance Level | $18.21 | $3.78 |
| Average True Range (ATR) | 0.95 | 0.08 |
| MACD | 0.20 | 0.01 |
| Stochastic Oscillator | 3.67 | 22.51 |
Fluence Energy Inc provides intelligent energy storage and optimization software for renewables and storage. Its energy storage solutions and operational services support a more resilient grid and help unlock the potential of renewable portfolios. The company's offerings include energy storage solutions, recurring operational and maintenance services, and Software-as-a-Service (SaaS) products designed to meet customer business needs, performance requirements, in-house capabilities, and risk profiles. Its service plans offer varying levels of training, maintenance, guarantees, warranties, and support for active system management. The company operates in the Americas, APAC and EMEA, with the majority of revenue coming from the Americas.
Evotec is a drug discovery partnership firm providing solutions to pharmaceutical and biotechnology companies, academic institutions, foundations, and nonprofit organizations. The company offers services in a variety of therapeutic areas, including central nervous system disorders, diabetes, inflammation, oncology, infectious diseases, and women's health. The shared R&D segment, roughly 80% of sales, provides drug discovery and manufacturing services on a typical fee-for-service basis and integrated drug discovery collaborations based on its proprietary, internally developed assets. The Just-Evotec Biologics segment, about 20% of sales, offers CDMO services for biologics. As of 2023, the company has over 5,000 employees and 18 production sites mainly in Europe and the United States.